INDOCO REMEDIES LTD
INDOCO REMEDIES LTD (India) holds 21 active US FDA Type II Drug Master Files and 3 inactive, has DMF or CEP filings on record for 25 active ingredients and is linked to 2 FDA-registered manufacturing sites. 8 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “INDOCO REMEDIES LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/indoco-remedies-ltd
Overview
INDOCO REMEDIES LTD is an active pharmaceutical ingredient (API) supplier with 21 active FDA Type II Drug Master Files, covering ALLOPURINOL USP; ALOGLIPTIN BENZOATE; APIXABAN; ARIPIPRAZOLE USP; BESIFLOXACIN HYDROCHLORIDE; BETAXOLOL HYDROCHLORIDE USP.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which INDOCO REMEDIES LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
INDOCO REMEDIES LTD holds 21 active (24 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- RIVAROXABAN USPActive2022-11-10
- LACOSAMIDE USP (PROCESS II)Active2022-03-17
- METOPROLOL SUCCINATE USPActive2020-09-24
- ARIPIPRAZOLE USPActive2019-07-03
- NEOSTIGMINE METHYLSULFATE USPActive2016-11-30
- CANAGLIFLOZINActive2016-10-18
- APIXABANActive2016-07-20
- ALOGLIPTIN BENZOATEActive2016-06-30
- LACOSAMIDE USPActive2015-07-10
- BESIFLOXACIN HYDROCHLORIDEActive2015-07-07
- FEBUXOSTAT HEMIHYDRATE (FORM G)Active2015-02-11
- BRINZOLAMIDE USPActive2014-04-02
- RASAGILINE MESYLATEActive2013-11-12
- BETAXOLOL HYDROCHLORIDE USPActive2011-09-22
- BROMFENAC SODIUMActive2011-08-18
- OLOPATADINE HYDROCHLORIDE USPActive2010-08-27
- DORZOLAMIDE HYDROCHLORIDE USPActive2010-05-05
- GLIMEPIRIDE USPActive2009-01-12
- DICYCLOMINE HYDROCHLORIDE USPActive2008-12-04
- BRIMONIDINE TARTRATE USPActive2008-10-29
- ALLOPURINOL USPActive2008-01-15
- QUETIAPINE FUMARATEInactive2011-10-14
- CIPROFLOXACIN HYDROCHLORIDE USPInactive2008-08-11
- Metformin Hydrochloride USP, as maufactured in Raigad District, INDIAInactive2007-12-05
Registered manufacturing sites (2)
Physical sites registered with the US FDA and resolved to INDOCO REMEDIES LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
8 FDA enforcement records linked to this company.
- warning_letter2024-12-16
FDA Warning Letter (drug product)
- 4832023-02-28
Environmental Monitoring System
- 4832023-02-28
Scientifically sound laboratory controls
- 4832023-02-28
Procedures for sterile drug products
- 4832023-02-28
Equipment to control conditions
- 4832018-11-21
Procedures not in writing, fully followed
- 4832018-11-21
Complaint Handling Procedure
- warning_letter2017-03-31
FDA Warning Letter (drug product)
Is this INDOCO REMEDIES LTD?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.